Prevention of Cytomegalovirus Reactivation in Haploidentical Stem Cell Transplantation-Reference-Cited by-同舟云学术

Prevention of Cytomegalovirus Reactivation in Haploidentical Stem Cell Transplantation

Published:2018-02 Issue:2 Volume:24 Page:353-358
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Hammerstrom Aimee E.,Lombardi Lindsey R.,Pingali Sai Ravi,Rondon Gabriela,Chen Julianne,Milton Denái R.,Chemaly Roy F.,Champlin Richard E.,Gulbis Alison,Ciurea Stefan O.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference31 articles.

1. The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy;Boeckh;Blood,2004

2. High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection;Nichols;J Infect Dis,2002

3. Cytomegalovirus inhibits the engraftment of donor bone marrow cells by downregulation of hemopoietin gene expression in recipient stroma;Steffens;J Virol,1998

4. Cytomegalovirus-induced CD13-specific autoimmunity—a possible cause of chronic graft-vs-host disease;Söderberg;Transplantation,1996

5. Guidelines for preventing infectious complications among hematopoietic stem cell transplantation recipients: a global perspective;Tomblyn;Biol Blood Marrow Transplant,2009

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Haploidentical Stem Cell Transplantation With TCR αβ+/CD19+ Depletion in Children With Nonmalignant Hematologic Disorders: Outcomes From a Referral Center in Peru;Transplantation Proceedings;2024-09

2. Haploidentical versus Cord Blood Transplantation in Pediatric AML. A Retrospective Outcome Analysis on Behalf of the Pediatric Subcommittee of GETH (Grupo Español de Trasplante Hematopoyético);Transplantation and Cellular Therapy;2024-07

3. Use of Letermovir for CMV Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: Review of the Literature and Single-Center Real-Life Experience;Hemato;2023-04-28

4. Cytomegalovirus Infection Post Stem Cell Transplant;Basics of Hematopoietic Stem Cell Transplant;2023

5. Effective CMV prophylaxis with high‐dose valaciclovir in allogeneic hematopoietic stem‐cell recipients at a high risk of CMV infection;Transplant Infectious Disease;2022-12